By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


ImmuneRegen BioSciences, Inc. 

4021 N. 75th At., Suite 201

Scottsdale  Arizona  85251  U.S.A.
Phone: 480-922-3926 or 866-922-3926 Fax: 480-222-3295



Company News
ImmuneRegen BioSciences, Inc. (IRBO) Reports Positive Results in Cancer Vaccine Studies in Radboud University Nijmegen Medical Centre Collaboration 10/28/2010 11:24:35 AM
ImmuneRegen BioSciences, Inc. (IRBO) Reports Scancell Collaboration Yielding Positive Results in Cancer Vaccine Studies of Homspera(R) 9/8/2010 11:19:49 AM
Scancell Release: Collaboration With ImmuneRegen BioSciences, Inc. (IRBO) Yields Positive Results in Cancer Vaccine Studies 9/7/2010 9:04:13 AM
ImmuneRegen BioSciences, Inc. (IRBO) Invited to Submit Full Proposal to Biomedical Advanced Research and Development Authority (BARDA) for Homspera(R) as a Potential Medical Countermeasure for Injury Associated With Radiation Exposure 8/31/2010 1:37:37 PM
University of Rochester Medical Center Receives $15 Million in Government Funding to Research ImmuneRegen BioSciences, Inc. (IRBO)'s Homspera(R) 8/25/2010 8:23:56 AM
ImmuneRegen BioSciences, Inc. (IRBO) Completes Successful Reduction of Debt 8/4/2010 10:59:17 AM
Scancell Enters Strategic Collaboration with ImmuneRegen BioSciences, Inc. (IRBO)(R) 6/4/2010 9:46:09 AM
ImmuneRegen BioSciences, Inc. (IRBO) Announces Collaboration With the Department of Tumor Immunology of the Radboud University Nijmegen Medical Centre, the Netherlands 4/27/2010 10:58:57 AM
NeoStem, Inc. and ImmuneRegen BioSciences, Inc. (IRBO) to Collaborate on Stem Cells 4/23/2010 1:59:32 PM
ImmuneRegen BioSciences, Inc. (IRBO) Initiates Strategic Collaboration With MPI Research to Accelerate Clinical Development of Lead Indications 4/21/2010 11:47:20 AM